REG - IP Group PLC - Notice of Capital Markets Event

IPAnnouncement

21/05/2025 10:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250521:nRSU6001Ja&default-theme=true

RNS Number : 6001J  IP Group PLC  21 May 2025

 FOR RELEASE ON  21 May 2025

 

IP Group plc - Notice of Capital Markets Event

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which invests in
breakthrough science and innovation companies with the potential to create a
better future for all, announces that it will hold a Capital Markets Event for
investors and analysts on Thursday June 26, 2025.

The event, which will be hosted by CEO Greg Smith and CFOO David Baynes, will
include presentations on the Group's investment strategy, pipeline, major
themes and portfolio companies. In addition, the agenda will also include
presentations from three portfolio companies, one from each of its three
respective thematic sectors - Hysata (cleantech), Intrinsic (deeptech) and
Genomics (life sciences).

Capital Markets Event details

The Capital Markets Event will be held at the offices of Deutsche Numis,

45 Gresham Street, London, EC2V 7BF and will start at 3pm. To register for the
event, please email lisa.alberti@dbnumis.com (mailto:lisa.alberti@dbnumis.com)
.

Further details can also be found on the events section of our website:
https://www.ipgroupplc.com/news-and-events/events
(https://www.ipgroupplc.com/news-and-events/events) .

 

No material new information will be released by the Group during the
presentation.

 

For more information, please contact:

 

 IP Group plc                       www.ipgroupplc.com
 Liz Vaughan-Adams, Communications  +44 (0) 20 7444 0062/+44 (0) 7967 312125
 Portland
 Alex Donaldson                     +44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. As the most
active UK based, early stage science investor, we develop and support some of
the world's most exciting businesses in deeptech, life sciences and cleantech
(led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund
manager, we also back world-changing innovation emerging in leading
universities and research institutions. Our specialist investment team
combines sector expertise with an international approach. Together we have a
strong track record of success, having backed high-profile companies including
Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP
Group is listed on the Main Market of the London Stock Exchange under the code
IPO. For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSEWSUFEISEFI